Deep Track Capital, LP 13D and 13G filings for RAPT Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-23 4:42 pm Purchase |
2024-12-23 | 13G | RAPT Therapeutics, Inc. RAPT |
Deep Track Capital, LP | 14,116,000 9.870% |
14,116,000 (New Position) |
Filing |
| 2024-11-14 09:39 am Sale |
2024-09-30 | 13G | RAPT Therapeutics, Inc. RAPT |
Deep Track Capital, LP | 0 0.000% |
-1,793,966 (Position Closed) |
Filing |
| 2024-02-14 08:52 am Sale |
2023-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
Deep Track Capital, LP | 1,793,966 5.220% |
-197,437 (-9.91%) |
Filing |
| 2023-10-23 4:40 pm Purchase |
2023-10-13 | 13G | RAPT Therapeutics, Inc. RAPT |
Deep Track Capital, LP | 1,991,403 5.800% |
1,991,403 (New Position) |
Filing |